[{"NetIncomeLoss_1_Q2_USD":442074000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":42799000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":80864000.0,"FinancingReceivableAllowanceForCreditLossesRecovery_2_Q2_USD":289587000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q2_USD":159902000.0,"NetIncomeLossAttributableToNoncontrollingInterest_2_Q2_USD":197758000.0,"FinancingReceivableAllowanceForCreditLosses_0_Q2_USD":1193449000.0,"OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTaxParent_2_Q2_USD":4066000.0,"EquityMethodInvestments_0_Q2_USD":430296000.0,"OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesNetOfTax_2_Q2_USD":24022000.0,"Liabilities_0_Q2_USD":6290595000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":2443430000.0,"OtherAssetsNoncurrent_0_Q2_USD":0.0,"AmortizationOfIntangibleAssets_1_Q2_USD":5733000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":11466000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":447399000.0,"RepaymentsOfLongTermDebt_2_Q2_USD":5170396000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":565758000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q2_USD":1624000.0,"OtherNoncashIncomeExpense_2_Q2_USD":-3398000.0,"LongTermDebtCurrent_0_Q2_USD":182226000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q2_shares":1000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_2_Q2_shares":1000.0,"AssetsCurrent_0_Q2_USD":3390789000.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q2_USD":34366000.0,"NotesAndLoansReceivableNetNoncurrent_0_Q2_USD":11169857000.0,"ProvisionForLoanLossesExpensed_2_Q2_USD":108683000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":1909332000.0,"StockIssuedDuringPeriodValueNewIssues_2_Q2_USD":1909332000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-922316000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":30515000.0,"InterestPaidNet_2_Q2_USD":83431000.0,"FinancingReceivableAllowanceForCreditLossesWriteOffs_2_Q2_USD":262980000.0,"DerivativeLiabilitiesCurrent_0_Q2_USD":0.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_2_Q2_USD":11296000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":0.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":33472000.0,"OtherAssetsCurrent_0_Q2_USD":12789000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":0.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":261000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-5662000.0,"GainsLossesOnExtinguishmentOfDebt_2_Q2_USD":-5405000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":353980000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":353980000.0,"EquitySecuritiesFvNiUnrealizedGainLoss_1_Q2_USD":193895000.0,"EquitySecuritiesFvNiUnrealizedGainLoss_2_Q2_USD":40729000.0,"MinorityInterest_0_Q2_USD":5237829000.0,"EarningsPerShareBasic_1_Q2_USD":0.09,"EarningsPerShareBasic_2_Q2_USD":0.09,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":565958000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":5776000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":13415000.0,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":-45635000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":0.0,"NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":33472000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_2_Q2_USD":48378000.0,"Revenues_2_Q2_USD":1011811000.0,"IncreaseDecreaseInFinanceReceivables_2_Q2_USD":937021000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":353717000.0,"NotesReceivableNet_0_Q2_USD":11696794000.0,"DerivativeAssetsNoncurrent_0_Q2_USD":14717000.0,"CostsAndExpenses_1_Q2_USD":101586000.0,"CostsAndExpenses_2_Q2_USD":241035000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":2121956000.0,"IncreaseDecreaseInOtherCurrentAssets_2_Q2_USD":12634000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":13862000.0,"FinancingReceivableChangeInPresentValueExpenseReversal_2_Q2_USD":2964000.0,"DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_2_Q2_USD":8897000.0,"InvestmentIncomeNet_1_Q2_USD":2724000.0,"InvestmentIncomeNet_2_Q2_USD":5582000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q2_USD":162454000.0,"Revenues_1_Q2_USD":510932000.0,"EquityMethodInvestmentDividendsOrDistributions_2_Q2_USD":31840000.0,"ProceedsFromIssuanceOfLongTermDebt_2_Q2_USD":6040000000.0,"OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax_2_Q2_USD":4066000.0,"OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax_1_Q2_USD":0.0,"TradingSecuritiesDebt_0_Q2_USD":343679000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":353979000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":353979000.0,"ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_2_Q2_USD":0.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":960108000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":3740000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":3740000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":601976000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":711072000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":65833000.0,"PaymentsToAcquireFinanceReceivables_2_Q2_USD":574620000.0,"IncomeLossFromEquityMethodInvestments_2_Q2_USD":20218000.0,"IncomeLossFromEquityMethodInvestments_1_Q2_USD":29292000.0,"NotesReceivableGross_0_Q2_USD":12890243000.0,"PaymentsToAcquireEquityMethodInvestments_2_Q2_USD":29262000.0,"LiabilitiesCurrent_0_Q2_USD":450973000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":637235000.0,"PaymentsOfDebtIssuanceCosts_2_Q2_USD":8819000.0,"NonoperatingIncomeExpense_1_Q2_USD":192630000.0,"NetIncomeLoss_2_Q2_USD":513314000.0,"ProvisionForLoanAndLeaseLosses_2_Q2_USD":135290000.0,"ProvisionForLoanAndLeaseLosses_1_Q2_USD":47278000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":40258000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":9394961000.0,"NotesAndLoansReceivableNetCurrent_0_Q2_USD":526937000.0,"AdditionalPaidInCapital_0_Q2_USD":2557237000.0,"ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_2_Q2_USD":15084000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_1_Q2_USD":33472000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_2_Q2_USD":33472000.0,"LongTermDebtNoncurrent_0_Q2_USD":5729622000.0,"IncreaseDecreaseInOtherReceivables_2_Q2_USD":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":2443430000.0,"InterestExpense_1_Q2_USD":34189000.0,"InterestExpense_2_Q2_USD":87773000.0,"NonoperatingIncomeExpense_2_Q2_USD":-59704000.0,"IncreaseDecreaseInDerivativeLiabilities_2_Q2_USD":-34952000.0,"EarningsPerShareDiluted_1_Q2_USD":0.09,"EarningsPerShareDiluted_2_Q2_USD":0.09,"OperatingIncomeLoss_2_Q2_USD":770776000.0,"ShareBasedCompensation_2_Q2_USD":3740000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":6949000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":63740000.0,"Assets_0_Q2_USD":15685556000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":190954000.0,"ProceedsFromInterestReceived_2_Q2_USD":3597000.0,"GainLossOnDerivativeInstrumentsNetPretax_1_Q2_USD":647000.0,"GainLossOnDerivativeInstrumentsNetPretax_2_Q2_USD":-32798000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q2_USD":6949000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2_Q2_USD":59674000.0,"TreasuryStockValue_0_Q2_USD":2119000.0,"DueToRelatedPartiesCurrent_0_Q2_USD":122771000.0,"MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_1_Q2_USD":296483000.0,"MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_2_Q2_USD":689684000.0,"OperatingIncomeLoss_1_Q2_USD":409346000.0,"PaymentsForRepurchaseOfCommonStock_2_Q2_USD":0.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":28500000.0,"ProceedsFromIssuanceInitialPublicOffering_2_Q2_USD":1918229000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":2159748000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":1571399000.0,"AmortizationOfFinancingCostsAndDiscounts_2_Q2_USD":4340000.0,"TransferOfInvestments_2_Q2_USD":303679000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":125121000.0,"UnrealizedGainLossOnDerivatives_2_Q2_USD":-32798000.0,"PaymentsToMinorityShareholders_2_Q2_USD":284546000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q2_USD":449023000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":110000000.0,"ProfitLoss_2_Q2_USD":711072000.0,"ProfitLoss_1_Q2_USD":601976000.0,"DerivativeLiabilitiesNoncurrent_0_Q2_USD":0.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":3700000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":3700000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":15685556000.0,"FiniteLivedIntangibleAssetsGross_0_Q2_USD":606216000.0,"ProfitLoss_0_Q2_USD":86187000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2_Q2_USD":577054000.0,"Ticker":"RPRX","CIK":"1802768","name":"ROYALTY PHARMA PLC","OfficialName":"Royalty Pharma plc Class A Ordinary Shares ","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"19213987432.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200812"}]